BCKDK mRNA expression, remained unaltered in the class I obese patients, decreased in class II obesity and increased in the class III obese group (when compared to the pre-obese patients) (Figure 4D). This evidence concerns the gene BCKDK and obesity due to melanocortin 4 receptor deficiency.